In the Public Interest?

Science Translational Medicine  25 Jul 2012:
Vol. 4, Issue 144, pp. 144fs23
DOI: 10.1126/scitranslmed.3003612

You are currently viewing the abstract.

View Full Text


Restrictive patenting and licensing for cell-free fetal DNA testing has serious consequences for technology advances and benefits to public health.

View Full Text